Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes.
about
Ex vivo T2 relaxation: associations with age-related neuropathology and cognitionFourier transform infrared imaging showing reduced unsaturated lipid content in the hippocampus of a mouse model of Alzheimer's disease.Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer's disease, and dementia with Lewy bodiesLeukoaraiosis severity and list-learning in dementiaBrain networks in posterior cortical atrophy: a single case tractography study and literature review.Callosal microstructural abnormalities in Alzheimer's disease and alcoholism: same phenotype, different mechanisms.Neuropsychological near normality and brain structure abnormality in schizophreniaThe correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer's disease.Interactive effects of apolipoprotein E4 and diabetes risk on later myelinating white matter regions in neurologically healthy older aged adultsCigarette Smoke-Induced Alterations in Frontal White Matter Lipid Profiles Demonstrated by MALDI-Imaging Mass Spectrometry: Relevance to Alzheimer's DiseaseIron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementiasCollapsin response mediator protein-2 phosphorylation promotes the reversible retraction of oligodendrocyte processes in response to non-lethal oxidative stress.Altered temporal lobe white matter lipid ion profiles in an experimental model of sporadic Alzheimer's disease.Magnetic resonance imaging of myelin.White matter atrophy in Alzheimer's disease variants.Cell number changes in Alzheimer's disease relate to dementia, not to plaques and tangles.3D tract-specific local and global analysis of white matter integrity in Alzheimer's disease.Review: Astrocytes in Alzheimer's disease and other age-associated dementias: a supporting player with a central role.Lessons from a mouse model characterizing features of vascular cognitive impairment with white matter changesEx vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia.White Matter Changes in Bipolar Disorder, Alzheimer Disease, and Mild Cognitive Impairment: New Insights from DTI.Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.Axonal Degeneration in Tauopathies: Disease Relevance and Underlying Mechanisms.Regionally specific changes in the hippocampal circuitry accompany progression of cerebrospinal fluid biomarkers in preclinical Alzheimer's disease.In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA.White matter changes in familial Alzheimer's disease.Contributors to white matter damage in the frontal lobe in Alzheimer's disease.The Biology of Glial Cells and Their Complex Roles in Alzheimer's Disease: New Opportunities in Therapy
P2860
Q30767891-8D397966-48E6-4EA0-8339-4BA6634B5E55Q33764514-0B82E852-8D95-45B8-8644-D783BF1C3B21Q33771165-9C98D3D1-69C6-4FA3-985C-7C958B994C9DQ33835694-C4E2662C-D0CC-49DD-B2EA-DBBEB36006FCQ34078693-6247F571-1A24-4828-A725-CC587EC02DE6Q34171511-897E2362-356F-4611-9B8B-6D5D5F6D236FQ34887181-78DC69B6-6D6C-4B05-9600-D4C539567871Q35010262-14685F50-1CB4-496B-A770-978E9AC850B4Q35167347-C482AACB-FCB8-4238-86D5-7C5C740FC40CQ35912013-28A35063-9C78-46C9-B417-06C2C055C21BQ35954821-B056756A-B81C-4493-9868-A7B82D0FA925Q36019763-2EAFF825-C96B-4D03-8A56-46E9A4512DC5Q36355644-7915FCC9-AD67-4415-AC5C-205148F20F0CQ36864333-678EC189-0D6C-4258-8027-947D7366865FQ37030441-A36B10E0-FED9-4389-B492-38E5C3A1B660Q37383448-7F29A849-D81C-4C24-A758-9D4BEE4AB678Q37633001-F41B367F-648F-4645-92EB-91F4F0DC91DDQ38904336-463D5896-6CD4-4A3B-BCBE-70511802C329Q39114617-5F296BDF-8A01-43C0-A17C-A9A7B24246A9Q39421399-B5A9E7A7-509F-44FE-8623-D8E29D7A914FQ39752120-D1394C19-BB2A-4F9F-B1F8-644E796C4E54Q41566472-7C6E2476-80E2-456A-8485-7E8C97E86413Q46985283-262FCC90-A63E-4381-B45E-4227FD852F65Q47324557-4469DD2F-F02F-4EB6-8F84-BA136D96F5C8Q48314517-49421100-2A80-4476-A1F0-31F8A7EC9E8FQ48350303-8C07BAE7-BF13-46F8-906A-C5E07388CF70Q48700189-D309A9EB-F758-4F8E-B4CA-FDA07FBAD3FEQ57927442-20A216E3-5EED-439F-A320-A13FF93ED328
P2860
Glial levels determine severity of white matter disease in Alzheimer's disease: a neuropathological study of glial changes.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Glial levels determine severit ...... ogical study of glial changes.
@ast
Glial levels determine severit ...... ogical study of glial changes.
@en
type
label
Glial levels determine severit ...... ogical study of glial changes.
@ast
Glial levels determine severit ...... ogical study of glial changes.
@en
prefLabel
Glial levels determine severit ...... ogical study of glial changes.
@ast
Glial levels determine severit ...... ogical study of glial changes.
@en
P2860
P1476
Glial levels determine severit ...... logical study of glial changes
@en
P2093
P2860
P304
P356
10.1046/J.1365-2990.2003.00456.X
P577
2003-04-01T00:00:00Z